Black Mental Health Day -- Addressing cannabis and mental health research gaps for Black communities in Canada
OTTAWA, ON, March 7, 2022 /CNW/ - This Black Mental Health Day, the Mental Health Commission of Canada (MHCC) highlights a need for greater knowledge of cannabis use and mental health for Black communities in Canada.
To discuss cannabis use and mental health in Black communities is to discuss systemic racism and related structural issues in Canadian society.
After legalization there were many gaps in cannabis use and mental health research. Afro Cannada Budsistas co-founder Khadisha Thornhill points out how researchers forgot "marginalized and racialized communities most affected by the enforcement of its prohibition, especially with regard to education and de-programming negative stigma."
Thornhill believes gaps are slowly being closed with efforts to empower communities and to better understand cannabis and mental health. "It is necessary to challenge the historical distrust of government and policing efforts to pave the way for Black and Indigenous communities to finally have their voices and lived experiences heard and amplified."
The Mental Health Commission of Canada report, Amplifying Black Experiences in Cannabis and Mental Health Research, underscores the need to develop meaningful knowledge about mental health, cannabis, and Black communities, to create research in collaboration with these communities, not without them, and engage Black communities as equal partners.
"This work marks an important step, notably its inclusion of Black perspectives on issues that have affected Black communities for decades," said Dr. Akwasi Owusu-Bempah, an assistant professor of sociology at the University of Toronto. "It not only demonstrates what knowledge we need to develop, but also how that needs to be done: by using people's first-hand experience and ensuring that Black communities are equal partners in all aspects of research, education, and policy."
Themes that emerged
There is no single Black community ? there are many.
The relationship between cannabis use and mental health in Black communities is intertwined with systemic racism, structural violence, and traumas related to criminalization and stigmatization.
There is little research or credible public information on cannabis or its relationship to mental health ? either generally or for Black people.
Canada needs to take a race-based and intersectional approach to data on cannabis and mental health.
"This Black Mental Health Day the MHCC highlights the need to study cannabis in the proper cultural context, to empower Black researchers, and to validate personal and lived experience of cannabis use for mental health," affirmed Ed Mantler, MHCC vice-president of programs and priorities.
Quick Facts
In 2018, the MHCC received funding from Health Canada to explore the relationship between cannabis and mental health.
Between December 2020 and April 2021, the MHCC hosted a series of virtual dialogues that explored challenges and opportunities in areas of mental health and cannabis in Canada's Black communities.
The report's key findings and recommendations will be further discussed during a virtual panel discussion Moderated by Dr. Owusu-Bempah.
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness.
Palliative care is...
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure.
"It is my dream to be able to bring the P-Cure...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...